nausea and vomiting of pregnancy


Also found in: Acronyms.

nausea and vomiting of pregnancy

a common condition of early pregnancy characterized by recurrent or persistent nausea, often in the morning, that may result in vomiting, weight loss, anorexia, general weakness, and malaise. The causes of the condition are poorly understood. It usually does not begin before the sixth week after the last menstrual period and ends by the twelfth to the fourteenth week of pregnancy. Symptomatic relief is often obtained by eating small, easily digested meals frequently and by not allowing the stomach to be empty. In the past, antiemetic drugs were routinely prescribed for this complaint, but this practice is currently reserved for severe cases. Nausea and vomiting after the sixteenth week is an unusual complication of pregnancy, called persistent nausea and vomiting of pregnancy. If it is severe and intractable, hyperemesis gravidarum may ensue. Also called,
Usage notes: nontechnical,
morning sickness.
References in periodicals archive ?
With more than 28 years' experience managing more than 750,000 high-risk pregnancies as part of services like our Nausea and Vomiting of Pregnancy Program, and with a nationwide network of OB nurse specialists available 24/7, we are experts in developing solutions that improve maternal health," stated Gregg Raybuck, President, Alere Health.
is indicated for the treatment of nausea and vomiting of pregnancy in women who do not respond to conservative management.
Preemptive Diclectin therapy for the management of nausea and vomiting of pregnancy and hyperemesis gravidarum.
About Diclegis Diclegis (doxylamine succinate 10 mg, pyridoxine hydrochloride 10 mg) delayed-release tablets is the only FDA-approved prescription treatment for nausea and vomiting of pregnancy (NVP) in women who do not respond to conservative management.
doxylamine succinate and pyridoxine hydrochloride) Delayed-Release Tablets, for the treatment of Nausea and Vomiting of Pregnancy (NVP) in women who do not respond to conservative management,[1] are now available without prior authorization through the Connecticut state-administered Medicaid program.
July 9, 2015 /PRNewswire/ -- Duchesnay USA today announced that Diclegis (doxylamine succinate and pyridoxine hydrochloride) Delayed-Release Tablets for the treatment of Nausea and Vomiting of Pregnancy (NVP) in women who do not respond to conservative management[1] are now available through Humana's Commercial Prescription Drug Program.
There is also some evidence that the nausea and vomiting of pregnancy may be related to vitamin [B.
A wide range of oral and parenteral antiemetics is available to treat nausea and vomiting of pregnancy (NVP).
Only FDA-approved and only Pregnancy Category A prescription treatment for Nausea and Vomiting of Pregnancy is now available in Texas through the state-administered Medicaid Drug Rebate Program
Only FDA-approved and only Pregnancy Category A prescription treatment for Nausea and Vomiting of Pregnancy is now available in Tennessee through the state-administered Medicaid Drug Rebate Program (TennCare)
Only FDA-approved and only Pregnancy Category A prescription treatment for Nausea and Vomiting of Pregnancy is now available in California and Nebraska through state-administered Medicaid Drug Rebate Programs
Duchesnay USA encourages pregnant women suffering from nausea and vomiting of pregnancy to speak with their healthcare professional about the only FDA-approved and only Pregnancy Category A prescription treatment for morning sickness